These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5404004)

  • 21. Inhibition of Na+K+-activated adenosine triphosphatase activity in rat brain by substituted phenothiazines.
    Davis PW; Brody TM
    Biochem Pharmacol; 1966 Jun; 15(6):703-10. PubMed ID: 4381471
    [No Abstract]   [Full Text] [Related]  

  • 22. The binding of phenothiazines to oxyhemoglobin A and S.
    Wind M; Berliner A; Stella AS; Guttman C
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):759-66. PubMed ID: 4144819
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between the behavioral and electroencephalographic effects of chlorpromazine and fluphenazine in rats.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1975; 13(6):520-5. PubMed ID: 1221434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on the inhibition of Na + , K + -activated ATPase activity by chlorpromazine, promazine, imipramine, and their monodesmethyl metabolites.
    Hackenberg H; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(1):63-73. PubMed ID: 4262725
    [No Abstract]   [Full Text] [Related]  

  • 25. ALTERATIONS IN RESPONSE TO SOMATIC PAIN ASSOCIATED WITH ANAESTHESIA. XV. FURTHER STUDIES WITH PHENOTHIAZINE DERIVATIVES AND SIMILAR DRUGS.
    DUNDEE JW; LOVE WJ; MOORE J
    Br J Anaesth; 1963 Oct; 35():597-610. PubMed ID: 14073476
    [No Abstract]   [Full Text] [Related]  

  • 26. Efflux of chlorpromazine and trifluoperazine from the rat brain.
    Spano PF; Neff NH; Macko E; Costa E
    J Pharmacol Exp Ther; 1970 Jul; 174(1):20-6. PubMed ID: 5424702
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hydrophobic character of phenothiazine derivatives as determining factor for their initial uptake by the isolated perfused rat liver].
    Jähnchen E; Krieglstein J; Kunkel F; Samuelis WJ
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):363-4. PubMed ID: 4254339
    [No Abstract]   [Full Text] [Related]  

  • 28. Conversion of phenothiazine derivatives to the corresponding sulphoxides on thin-layer plates.
    Kofoed J; Korczak-Fabierkiewicz C; Lucas GH
    Nature; 1966 Jul; 211(5045):147-50. PubMed ID: 5965512
    [No Abstract]   [Full Text] [Related]  

  • 29. STUDIES OF DRUGS GIVEN BEFORE ANAESTHESIA. VI. THE PHENOTHIAZINE DERIVATIVES.
    DUNDEE JW; MOORE J; LOVE WJ; NICHOLL RM; CLARKE RS
    Br J Anaesth; 1965 May; 37():332-53. PubMed ID: 14314889
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of the receptor component of adenylate cyclase in the rat brain by phenothiazine derivatives.
    Palmer GC; Manian AA
    Neuropharmacology; 1974 Sep; 13(9):851-66. PubMed ID: 4154419
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of phenothiazines and phenothiazine metabolites on adenyl cyclase and the cyclic AMP response in the rat brain.
    Palmer GC; Manian AA
    Adv Biochem Psychopharmacol; 1974; 9(0):749-67. PubMed ID: 4365287
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of chlorpromazine and promazine on the visual aftereffects of tilt and movement.
    Harris JP; Phillipson OT; Watkins GM; Whelpton R
    Psychopharmacology (Berl); 1983; 79(1):49-57. PubMed ID: 6403965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cerebral and hepatic fixation of phenothiazine and iminodibenzyl derivatives in rats].
    Stephan Y; Welin L; Mainard F
    C R Acad Hebd Seances Acad Sci D; 1972 Sep; 275(10):1087-9. PubMed ID: 4629719
    [No Abstract]   [Full Text] [Related]  

  • 34. Chlorpromazine and the eye of the dog. VI. A comparison of phenothiazine tranquilizers.
    Barron CN; Murchison TE; Rubin LF; Rubin ML; Herron W; Muscarella M; Birkhead H
    Exp Mol Pathol; 1972 Apr; 16(2):172-9. PubMed ID: 5062562
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 36. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T-wave changes in the dog following intravenous administration of chlorpromazine and fluphenazine.
    Hassert GL; Peterson AE; Burke JC
    Nature; 1965 Aug; 207(998):765-6. PubMed ID: 5885925
    [No Abstract]   [Full Text] [Related]  

  • 38. Experience with greater than recommended doses of fluphenazine and triflupromazine.
    Kushner T
    Am J Psychiatry; 1966 Mar; 122(9):1061-2. PubMed ID: 5903250
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of phenothiazine-class antipsychotics on the function of α7-nicotinic acetylcholine receptors.
    Ashoor A; Lorke D; Nurulain SM; Kury LA; Petroianu G; Yang KH; Oz M
    Eur J Pharmacol; 2011 Dec; 673(1-3):25-32. PubMed ID: 22044918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side-chain degradation and ring hydroxylation of pehnothiazine tranquilizers.
    Fishman V; Goldenberg H
    J Pharmacol Exp Ther; 1965 Oct; 150(1):122-8. PubMed ID: 5853692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.